US 12031130
Composition for modifying target gene
granted A61KA61K31/7105A61K38/465
Quick answer
US patent 12031130 (Composition for modifying target gene) held by Takeda Pharmaceutical Company Limited expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/7105, A61K38/465, A61K47/24, A61K9/0019